Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects

Ertugliflozin, a sodium‐glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus, prevents renal glucose reabsorption resulting in urinary glucose excretion. This open‐label, parallel cohort, randomized study conducted in healthy Chinese adults residing in China assessed the p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Pharmacol Drug Dev
Huvudupphovsmän: Li, Yinhua, Mu, Yuting, Shi, Haihong, Liang, Yali, Liu, Zeyuan, Matschke, Kyle, Hickman, Anne, Krishna, Rajesh, Sahasrabudhe, Vaishali
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2019
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7003779/
https://ncbi.nlm.nih.gov/pubmed/30934166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.686
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk